SCHEMBL23624813

SCHEMBL23624813

Cc1ccc(S(=O)(=O)OCC(CC#N)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
GLA P06280 1/20 0.39
PKM P14618 1/20 0.38
VDR P11473 1/20 0.38
DHODH Q02127 1/20 0.38
MAPT P10636 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CYP2D6 P10635 2/20 0.37
MAPK1 P28482 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
STAT3 P40763 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPC1 O15118 1/20 0.37
NFKB1 P19838 1/20 0.37
S100A4 P26447 1/20 0.37
MTOR P42345 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25403099 0.89 ALDH1A1 (0.45) ALDH1A1PKMVDRDHODHCYP2D6
SCHEMBL26286109 0.85 CCR5 (0.44) ALDH1A1PKMVDRDHODHCYP2D6
SCHEMBL4583291 0.83 PKM (0.42) ALDH1A1PKMVDRDHODHMAPT
SCHEMBL19725071 0.82 CA2 (0.44) ALDH1A1PKMMEN1KMT2ACYP1A2
SCHEMBL9172287 0.81 GLA (0.44) ALDH1A1GLAVDRDHODHMAPT
SCHEMBL4432214 0.81 CA12 (0.46) ALDH1A1PKMVDRDHODHCYP2D6
SCHEMBL3446685 0.79 ALDH1A1 (0.46) ALDH1A1GLADHODHMAPTTDP1
SCHEMBL2941143 0.79 ALDH1A1 (0.46) ALDH1A1GLADHODHMAPTTDP1
SCHEMBL2938778 0.79 ALDH1A1 (0.46) ALDH1A1GLADHODHMAPTTDP1
SCHEMBL1031702 0.79 ALDH1A1 (0.44) ALDH1A1PKMVDRDHODHSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210205461-A1 Rapidly Released Bioorthogonal Caging Groups UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210205461-A1 Rapidly Released Bioorthogonal Caging Groups CBR3, CBR1, CNOT9 ALDH1A1 3686/4885GLA 3943/4885PKM 4810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.